{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:47:58Z","timestamp":1765961278413,"version":"build-2065373602"},"reference-count":101,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>A wide diversity of zoonotic viruses that are capable of overcoming host range barriers facilitate the emergence of new potentially pandemic viruses in the human population. When faced with a new virus that is rapidly emerging in the human population, we have a limited knowledge base to work with. The pandemic invasion of the new SARS-CoV-2 virus in 2019 provided a unique possibility to quickly learn more about the pathogenesis of respiratory viruses. In this review, the impact of pandemics on the circulation of seasonal respiratory viruses is considered. The emergence of novel respiratory viruses has often been accompanied by the disappearance of existing circulating strains. Some issues arising from the spread of pandemic viruses and underlying the choices of a strategy to fight the coronavirus infection are discussed.<\/jats:p>","DOI":"10.3390\/biology9090240","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T09:35:31Z","timestamp":1597916131000},"page":"240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["COVID-19 in Light of Seasonal Respiratory Infections"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-9873","authenticated-orcid":false,"given":"Irina","family":"Kiseleva","sequence":"first","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cInstitute of Experimental Medicine\u201d, 197376 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Grigorieva","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cInstitute of Experimental Medicine\u201d, 197376 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1171-3383","authenticated-orcid":false,"given":"Natalie","family":"Larionova","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cInstitute of Experimental Medicine\u201d, 197376 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0017-4126","authenticated-orcid":false,"given":"Mohammad","family":"Al Farroukh","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cInstitute of Experimental Medicine\u201d, 197376 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Rudenko","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cInstitute of Experimental Medicine\u201d, 197376 Saint Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Belser, J.A. (2020). Assessment of SARS-CoV-2 replication in the context of other respiratory viruses. Lancet. Respir. Med.","DOI":"10.1016\/S2213-2600(20)30227-7"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1073\/pnas.0604157103","article-title":"The guinea pig as a transmission model for human influenza viruses","volume":"103","author":"Lowen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bengoechea, J.A., and Bamford, C.G.G. (2020). SARS-CoV-2, bacterial co-infections, and AMR: The deadly trio in COVID-19?. EMBO Mol. Med.","DOI":"10.32415\/jscientia_2020_6_5_42-50"},{"key":"ref_4","unstructured":"WHO (2020, August 12). Coronavirus Disease (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF03391605","article-title":"Influenza pandemics: Past, present and future challenges","volume":"32","author":"Flahault","year":"2010","journal-title":"Public Health Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2672.2001.01492.x","article-title":"A history of influenza","volume":"91","author":"Potter","year":"2001","journal-title":"J. Appl. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Palese, P., and Wang, T.T. (2011). Why do influenza virus subtypes die out? A hypothesis. mBio, 2.","DOI":"10.1128\/mBio.00150-11"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Simonsen, L., Spreeuwenberg, P., Lustig, R., Taylor, R.J., Fleming, D.M., Kroneman, M., Van Kerkhove, M.D., Mounts, A.W., and Paget, W.J. (2013). Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: A modeling study. PLoS Med., 10.","DOI":"10.1371\/journal.pmed.1001558"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/irv.12249","article-title":"Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses","volume":"8","author":"Meningher","year":"2014","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0213-005X(12)70101-5","article-title":"Circulation of other respiratory viruses and viral co-infection during the 2009 pandemic influenza","volume":"30","author":"Reina","year":"2012","journal-title":"Enferm. Infecc. Y Microbiol. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Casalegno, J.S., Ottmann, M., Bouscambert-Duchamp, M., Valette, M., Morfin, F., and Lina, B. (2010). Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009. Eur. Commun. Dis. Bull., 15.","DOI":"10.2807\/ese.15.06.19485-en"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/j.1750-2659.2011.00323.x","article-title":"The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009-2011","volume":"6","author":"Mak","year":"2012","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.mehy.2011.09.021","article-title":"Virus interference. Did rhinoviruses activity hamper the progress of the 2009 influenza A (H1N1) pandemic in Norway?","volume":"77","year":"2011","journal-title":"Med Hypotheses"},{"key":"ref_18","first-page":"vex011","article-title":"Viral coinfection is shaped by host ecology and virus-virus interactions across diverse microbial taxa and environments","volume":"3","year":"2017","journal-title":"Virus Evol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.aivir.2020.02.001","article-title":"Implications of mixed viral infections on plant disease ecology and evolution","volume":"106","author":"Alcaide","year":"2020","journal-title":"Adv. Virus Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/QAD.0000000000001504","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection","volume":"31","author":"Maurice","year":"2017","journal-title":"Aids"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Nowak, M.D., Sordillo, E.M., Gitman, M.R., and Paniz Mondolfi, A.E. (2020). Co-infection in SARS-CoV-2 infected patients: Where are influenza virus and rhinovirus\/enterovirus?. J. Med Virol.","DOI":"10.1002\/jmv.25953"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ou, X., Zhou, L., Huang, H., Lin, Y., Pan, X., and Chen, D. (2020). A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens. Travel Med. Infect. Dis., 101672.","DOI":"10.1016\/j.tmaid.2020.101672"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ozaras, R., Cirpin, R., Duran, A., Duman, H., Arslan, O., Bakcan, Y., Kaya, M., Mutlu, H., Isayeva, L., and Kebanl\u0131, F. (2020). Influenza and COVID-19 co-infection: Report of 6 cases and review of the Literature. J. Med Virol.","DOI":"10.1002\/jmv.26125"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rawson, T.M., Moore, L.S.P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., and Holmes, A. (2020). Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciaa530"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00762","DOI":"10.1016\/j.idcr.2020.e00762","article-title":"Co-Infection with SARS-COV-2 and parainfluenza in a young adult patient with pneumonia: Case report","volume":"20","author":"Rodriguez","year":"2020","journal-title":"IDCases"},{"key":"ref_26","first-page":"75","article-title":"Co-infection with SARS-CoV-2 and human metapneumovirus","volume":"103","author":"Lonks","year":"2020","journal-title":"Rhode Island Med. J."},{"key":"ref_27","first-page":"377","article-title":"Influenza A virus reassortment","volume":"385","author":"Steel","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s11262-018-1590-z","article-title":"Reassortment events in the evolution of hantaviruses","volume":"54","author":"Klempa","year":"2018","journal-title":"Virus Genes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jmv.20156","article-title":"Genetic diversity of influenza B virus: The frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community","volume":"74","author":"Matsuzaki","year":"2004","journal-title":"J. Med. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Brealey, J.C., Sly, P.D., Young, P.R., and Chappell, K.J. (2015). Viral bacterial co-infection of the respiratory tract during early childhood. FEMS Microbiol. Lett., 362.","DOI":"10.1093\/femsle\/fnv062"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0065-3527(08)60713-7","article-title":"Viral-bacterial synergistic interaction in respiratory disease","volume":"35","author":"Babiuk","year":"1988","journal-title":"Adv. Virus Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fcimb.2017.00338","article-title":"Mechanisms of severe mortality-associated bacterial co-infections following influenza virus infection","volume":"7","author":"Jia","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"27142","DOI":"10.1073\/pnas.1911083116","article-title":"Virus-virus interactions impact the population dynamics of influenza and the common cold","volume":"116","author":"Nickbakhsh","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20120150","DOI":"10.1098\/rstb.2012.0150","article-title":"Vacated niches, competitive release and the community ecology of pathogen eradication","volume":"368","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. Ser. BBiol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Bosch, A.A., Biesbroek, G., Trzcinski, K., Sanders, E.A., and Bogaert, D. (2013). Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003057"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"191ra184","DOI":"10.1126\/scitranslmed.3005982","article-title":"Identifying the interaction between influenza and pneumococcal pneumonia using incidence data","volume":"5","author":"Shrestha","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/oxfordjournals.bmb.a069760","article-title":"Viral interference and interferon","volume":"15","author":"Isaacs","year":"1959","journal-title":"Br. Med Bull."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF02908284","article-title":"Viral interference and interferon","volume":"5","author":"Dianzani","year":"1975","journal-title":"La Ric. Clin. E Lab."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hirsh, S., Hindiyeh, M., Kolet, L., Regev, L., Sherbany, H., Yaary, K., Mendelson, E., and Mandelboim, M. (2014). Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090515"},{"key":"ref_40","first-page":"001656","article-title":"Co-infection with influenza A and COVID-19","volume":"7","author":"Konala","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_41","unstructured":"WHO Overview of Influenza Activity Globally. Influenza Update N\u00b0 373 of 3 August 2020. Available online: http:\/\/www.who.int\/influenza\/surveillance_monitoring\/updates\/latest_update_GIP_surveillance."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijid.2020.05.008","article-title":"Characteristics of respiratory virus infection during the outbreak of 2019 novel coronavirus in Beijing","volume":"96","author":"Li","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ding, Q., Lu, P., Fan, Y., Xia, Y., and Liu, M. (2020). The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J. Med Virol.","DOI":"10.1002\/jmv.25781"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/S0140-6736(20)31052-7","article-title":"SARS-CoV-2 and influenza virus co-infection","volume":"395","author":"Bodro","year":"2020","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/INF.0000000000002688","article-title":"Coinfection of influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-COV-2)","volume":"39","author":"Wu","year":"2020","journal-title":"Pediatric Infect. Dis. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3201\/eid2606.200299","article-title":"Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China","volume":"26","author":"Wu","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e00775","DOI":"10.1016\/j.idcr.2020.e00775","article-title":"Co-infection with SARS-CoV-2 and influenza A virus","volume":"20","author":"Azekawa","year":"2020","journal-title":"IDCases"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Hashemi, S.A., Safamanesh, S., Ghafouri, M., Taghavi, M.R., Mohajer Zadeh Heydari, M.S., Namdar Ahmadabad, H., Ghasem Zadeh-Moghaddam, H., and Azimian, A. (2020). Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran. J. Med Virol.","DOI":"10.1002\/jmv.26014"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.34172\/aim.2020.04","article-title":"Co-infection of coronavirus disease 2019 and influenza A: A report from Iran","volume":"23","author":"Khodamoradi","year":"2020","journal-title":"Arch. Iran. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Wehl, G., Laible, M., and Rauchenzauner, M. (2020). Co-infection of SARS CoV-2 and influenza A in a pediatric patient in Germany. Klin. Padiatr.","DOI":"10.1055\/a-1163-7385"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wu, Q., Xing, Y., Shi, L., Li, W., Gao, Y., Pan, S., Wang, Y., Wang, W., and Xing, Q. (2020). Coinfection and other clinical characteristics of COVID-19 in children. Pediatrics.","DOI":"10.1542\/peds.2020-0961"},{"key":"ref_52","unstructured":"Osterhaus, A.D.M.E. (2020, June 25). Influenza and RSV in a COVID-19 world. The First ESWI Webinar 11 June 2020. Available online: https:\/\/eswi.org\/eswi-tv\/influenza-and-rsv-in-a-covid-19-world-full-webinar\/."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Jones, N. (2020, June 18). How Coronavirus Lockdowns Stopped Flu in its Tracks. Nature News. Available online: https:\/\/www.nature.com\/articles\/d41586-020-01538-8.","DOI":"10.1038\/d41586-020-01538-8"},{"key":"ref_54","unstructured":"WHO (2020, August 01). Coronavirus Disease (COVID-19) Pandemic. Press Conference of 15 June 2020. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lansbury, L., Lim, B., Baskaran, V., and Lim, W.S. (2020). Co-infections in people with COVID-19: A systematic review and meta-analysis. J. Infect.","DOI":"10.2139\/ssrn.3594598"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Duque, J.A., Orozco-Hern\u00e1ndez, J.P., Mar\u00edn-Medina, D.S., Cvetkovic-Vega, A., Aveiro-R\u00f3balo, T.R., Mondragon-Cardona, A., Failoc-Rojas, V.E., Guti\u00e9rrez-Ocampo, E., Villamizar-Pe\u00f1a, R., and Henao-Mart\u00ednez, J.F. (2020). Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?. J. Med. Virol.","DOI":"10.1002\/jmv.26089"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/jama.2020.6266","article-title":"Rates of co-infection between SARS-CoV-2 and other respiratory pathogens","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Li, Z.T., Chen, Z.M., Chen, L.D., Zhan, Y.Q., Li, S.Q., Cheng, J., Zhu, A.R., Chen, L.Y., Zhong, N.S., and Li, S.Y. (2020). Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China. J. Med. Virol.","DOI":"10.1002\/jmv.26073"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Kakuya, F., Okubo, H., Fujiyasu, H., Wakabayashi, I., Syouji, M., and Kinebuchi, T. (2020). The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses. Jpn. J. Infect. Dis.","DOI":"10.7883\/yoken.JJID.2020.181"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1542\/peds.2013-2216","article-title":"Human rhinovirus and disease severity in children","volume":"133","author":"Costa","year":"2014","journal-title":"Pediatrics"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Li, Y., Pillai, P., Miyake, F., and Nair, H. (2020). The role of viral co-infections in the severity of acute respiratory infections among children infected with respiratory syncytial virus (RSV): A systematic review and meta-analysis. J. Glob. Health, 10.","DOI":"10.7189\/jogh.10.010426"},{"key":"ref_62","unstructured":"Osterhaus, A.D.M.E. (2020, June 20). Clinical Manifestations of COVID-19, Influenza and RSV. The Second ESWI Webinar 18 June 2020. Available online: https:\/\/eswi.org\/eswi-tv\/clinical-manifestations-of-covid-19-influenza-and-rsv-full-webinar\/."},{"key":"ref_63","unstructured":"Osterhaus, A.D.M.E. (2020, June 30). Intervention Strategies for COVID-19, Influenza and RSV. The Third ESWI Webinar 23 June 2020. Available online: https:\/\/player.vimeo.com\/video\/431944051."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ajh.25785","article-title":"COVID-19 and mycoplasma pneumoniae coinfection","volume":"95","author":"Fan","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gayam, V., Konala, V.M., Naramala, S., Garlapati, P.R., Merghani, M.A., Regmi, N., Balla, M., and Adapa, S. (2020). Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA. J. Med. Virol.","DOI":"10.1002\/jmv.26026"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Stochino, C., Villa, S., Zucchi, P., Parravicini, P., Gori, A., and Raviglione, M.C. (2020). Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur. Respir. J.","DOI":"10.1183\/13993003.01708-2020"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Tadolini, M., Codecasa, L.R., Garc\u00eda-Garc\u00eda, J.M., Blanc, F.X., Borisov, S., Alffenaar, J.W., Andr\u00e9jak, C., Bachez, P., Bart, P.A., and Belilovski, E. (2020). Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases. Eur. Respir. J.","DOI":"10.1183\/13993003.01398-2020"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12941-020-00363-1","article-title":"Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes","volume":"19","author":"Togun","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Arashiro, T., Nakamura, S., Asami, T., Mikuni, H., Fujiwara, E., Sakamoto, S., Miura, R., Shionoya, Y., Honda, R., and Furukawa, K. (2020). SARS-CoV-2 and Legionella co-infection in a person returning from a Nile cruise. J. Travel Med., 27.","DOI":"10.1093\/jtm\/taaa053"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"van Arkel, A.L.E., Rijpstra, T.A., Belderbos, H.N.A., van Wijngaarden, P., Verweij, P.E., and Bentvelsen, R.G. (2020). COVID-19 associated pulmonary aspergillosis. Am. J. Respir. Crit. Care Med.","DOI":"10.1164\/rccm.202004-1038LE"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Blaize, M., Mayaux, J., Nabet, C., Lampros, A., Marcelin, A.G., Thellier, M., Piarroux, R., Demoule, A., and Fekkar, A. (2020). Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient. Emerg. Infect. Dis., 26.","DOI":"10.3201\/eid2607.201603"},{"key":"ref_72","first-page":"001652","article-title":"A case of coinfection with SARS-COV-2 and cytomegalovirus in the era of COVID-19","volume":"7","author":"Boccatonda","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_73","unstructured":"Benkovic, S., Kim, M., and Sin, E. (2020). 4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York. J. Med. Virol."},{"key":"ref_74","unstructured":"WHO (2020, August 12). Draft Landscape of COVID-19 Candidate Vaccines. Update of 10 August 2020. Available online: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2020.04.022","article-title":"Rational vaccine design in the time of COVID-19","volume":"27","author":"Burton","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_76","unstructured":"Lauerman, J., and Paton, J. (2020, August 02). The First COVID Vaccines May Not Prevent COVID Infection. Prognosis of 15 June 2020. Available online: https:\/\/www.bloomberg.com\/news\/articles\/2020-06-15\/the-first-covid-vaccines-may-not-prevent-you-from-getting-covid."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The Cytokine Storm in COVID-19: An Overview of the Involvement of the Chemokine\/Chemokine-Receptor System","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/infdis\/jiaa152","article-title":"Human challenge studies to accelerate coronavirus vaccine licensure","volume":"221","author":"Eyal","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Morris, K.V. (2020). The improbability of the rapid development of a vaccine for SARS-CoV-2. Mol. Ther. J. Am. Soc. Gene Ther.","DOI":"10.1016\/j.ymthe.2020.06.005"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1073\/pnas.2005456117","article-title":"News feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine","volume":"117","author":"Peeples","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41577-020-0323-4","article-title":"COVID-19 vaccine design: The Janus face of immune enhancement","volume":"20","author":"Hotez","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"100051","DOI":"10.1016\/j.jtauto.2020.100051","article-title":"Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity","volume":"3","year":"2020","journal-title":"J. Transl. Autoimmun."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ozdemir, C., Kucuksezer, U.C., and Tamay, Z.U. (2020). Is BCG vaccination affecting the spread and severity of COVID-19?. Allergy.","DOI":"10.1111\/all.14344"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Meena, J., Yadav, A., and Kumar, J. (2020). BCG vaccination policy and protection against COVID-19. Indian J. Pediatrics, 1.","DOI":"10.1007\/s12098-020-03371-3"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"109816","DOI":"10.1016\/j.mehy.2020.109816","article-title":"Relation between BCG coverage rate and COVID-19 infection worldwide","volume":"142","author":"Macedo","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13312-020-1872-0","article-title":"Demystifying BCG vaccine and COVID-19 relationship","volume":"57","author":"Kumar","year":"2020","journal-title":"Indian Pediatrics"},{"key":"ref_89","first-page":"207","article-title":"Stop playing with data: There is no sound evidence that Bacille Calmette-Gu\u00e9rin may avoid SARS-CoV-2 infection (for now)","volume":"91","author":"Gualerzi","year":"2020","journal-title":"Acta Bio-Med. Atenei Parm."},{"key":"ref_90","unstructured":"WHO (2020, August 01). Bacille Calmette-Gu\u00e9rin (BCG) Vaccination and COVID-19. Scientific Brief of 12 April 2020. Available online: https:\/\/www.who.int\/news-room\/commentaries\/detail\/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"O\u2019Connor, E., Teh, J., Kamat, A.M., and Lawrentschuk, N. (2020). Bacillus Calmette Gu\u00e9rin (BCG) Vaccination Use in the Fight Against COVID-19\u2014What\u2019s Old is New Again?. Future Oncol.","DOI":"10.2217\/fon-2020-0381"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41585-020-0325-9","article-title":"Could BCG be used to protect against COVID-19?","volume":"17","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Dunning, J., Thwaites, R.S., and Openshaw, P.J.M. (2020). Seasonal and pandemic influenza: 100 years of progress, still much to learn. Mucosal Immunol., 1\u20138.","DOI":"10.1038\/s41385-020-0287-5"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Antony, S.J., Almaghlouth, N.K., and Heydemann, E.L. (2020). Are co-infections with COVID-19 and Influenza low or underreported? An observational study examining current published literature including three new unpublished cases. J. Med. Virol.","DOI":"10.1002\/jmv.26167"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"109752","DOI":"10.1016\/j.mehy.2020.109752","article-title":"The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19","volume":"140","author":"Salem","year":"2020","journal-title":"Med Hypotheses"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12961-020-00571-3","article-title":"From COVID-19 research to vaccine application: Why might it take 17\u2009months not 17\u2009years and what are the wider lessons?","volume":"18","author":"Hanney","year":"2020","journal-title":"Health Res. Policy Syst."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Mukherjee, R. (2020). Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus. J. Biosci., 45.","DOI":"10.1007\/s12038-020-00040-7"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Merante, D. (2020). SARS-CoV-2, from its current highly contagious spreading toward the global development of an effective and safe vaccine: Challenges and uncertainties. Expert Opin. Drug Saf., 1\u20133.","DOI":"10.1080\/14740338.2020.1773789"},{"key":"ref_99","unstructured":"WHO (2020, August 01). Recommendations on the Composition of Influenza Virus Vaccines. Available online: https:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/en\/."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Bogaert, D., and Dockrell, D.H. (2020). 100 years of influenza research seen through the lens of Covid-19. Mucosal Immunol., 1\u20132.","DOI":"10.1038\/s41385-020-0291-9"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-animal-031412-103733","article-title":"Cross talk between animal and human influenza viruses","volume":"1","author":"Ozawa","year":"2013","journal-title":"Annu Rev Anim Biosci"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/9\/9\/240\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:04:08Z","timestamp":1760177048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/9\/9\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":101,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["biology9090240"],"URL":"https:\/\/doi.org\/10.3390\/biology9090240","relation":{},"ISSN":["2079-7737"],"issn-type":[{"type":"electronic","value":"2079-7737"}],"subject":[],"published":{"date-parts":[[2020,8,20]]}}}